DrugPatentWatch Database Preview
Aerie Pharms Inc Company Profile
Email this page to a colleague
What is the competitive landscape for AERIE PHARMS INC, and what generic alternatives to AERIE PHARMS INC drugs are available?
AERIE PHARMS INC has two approved drugs.
There are thirteen US patents protecting AERIE PHARMS INC drugs.
There are fifty-eight patent family members on AERIE PHARMS INC drugs in nine countries and twelve supplementary protection certificates in seven countries.
Summary for Aerie Pharms Inc
| International Patents: | 58 |
| US Patents: | 13 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Aerie Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aerie Pharms Inc | ROCKLATAN | latanoprost; netarsudil dimesylate | SOLUTION/DROPS;OPHTHALMIC | 208259-001 | Mar 12, 2019 | RX | Yes | Yes | 8,394,826 | ⤷ Try it Free | Y | Y | ⤷ Try it Free | ||
| Aerie Pharms Inc | ROCKLATAN | latanoprost; netarsudil dimesylate | SOLUTION/DROPS;OPHTHALMIC | 208259-001 | Mar 12, 2019 | RX | Yes | Yes | 9,415,043 | ⤷ Try it Free | Y | ⤷ Try it Free | |||
| Aerie Pharms Inc | RHOPRESSA | netarsudil mesylate | SOLUTION/DROPS;OPHTHALMIC | 208254-001 | Dec 18, 2017 | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | |||||
| Aerie Pharms Inc | RHOPRESSA | netarsudil mesylate | SOLUTION/DROPS;OPHTHALMIC | 208254-001 | Dec 18, 2017 | RX | Yes | Yes | 10,882,840 | ⤷ Try it Free | ⤷ Try it Free | ||||
| Aerie Pharms Inc | RHOPRESSA | netarsudil mesylate | SOLUTION/DROPS;OPHTHALMIC | 208254-001 | Dec 18, 2017 | RX | Yes | Yes | 9,096,569 | ⤷ Try it Free | Y | Y | ⤷ Try it Free | ||
| Aerie Pharms Inc | RHOPRESSA | netarsudil mesylate | SOLUTION/DROPS;OPHTHALMIC | 208254-001 | Dec 18, 2017 | RX | Yes | Yes | 9,931,336 | ⤷ Try it Free | Y | Y | ⤷ Try it Free | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Aerie Pharms Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2016515520 | ⤷ Try it Free |
| Australia | 2018202965 | ⤷ Try it Free |
| Netherlands | 301038 | ⤷ Try it Free |
| Spain | 2834451 | ⤷ Try it Free |
| Canada | 2929545 | ⤷ Try it Free |
| European Patent Office | 2326623 | ⤷ Try it Free |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Aerie Pharms Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 3053913 | 2020C/510 | Belgium | ⤷ Try it Free | PRODUCT NAME: RHOKIINSA - NETARSUDIL; AUTHORISATION NUMBER AND DATE: EU/1/19/1400 20191121 |
| 3053913 | 301038 | Netherlands | ⤷ Try it Free | PRODUCT NAME: NETARSUDIL, OF EEN ZOUT OF SOLVAAAT DAARVAN, IN HET BIJZONDER NETARSUDILMESYLAAT; REGISTRATION NO/DATE: EU/1/19/1400 20191121 |
| 3053913 | 2020/016 | Ireland | ⤷ Try it Free | PRODUCT NAME: NETARSUDIL, OR AN ENANTIOMER, DIASTEREOMER, SALT OR SOLVATE THEREOF; REGISTRATION NO/DATE: EU/1/19/1400 20191121 |
| 3053913 | 132020000000043 | Italy | ⤷ Try it Free | PRODUCT NAME: NETARSUDIL(RHOKIINSA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/19/1400, 20191121 |
| 3053913 | 20C1017 | France | ⤷ Try it Free | PRODUCT NAME: NETARSUDIL, OU ENANTIOMERE, DIASTEREOMERE, SEL OU SOLVATE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/19/1400 20191121 |
| 3461484 | 122021000036 | Germany | ⤷ Try it Free | PRODUCT NAME: LATANOPROST, ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, UND NETARSUDIL MESYLAT; REGISTRATION NO/DATE: EU/1/20/1502 20210107 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
